43 related articles for article (PubMed ID: 38604061)
1. A Predictive Toxicokinetic Model for Nickel Leaching from Vascular Stents.
Giakoumi M; Stephanou PS; Kokkinidou D; Papastefanou C; Anayiotos A; Kapnisis K
ACS Biomater Sci Eng; 2024 Apr; 10(4):2534-2551. PubMed ID: 38525821
[No Abstract] [Full Text] [Related]
2. Bayesian analysis of physiologically based toxicokinetic (PBTK) modeling for pentachlorophenol exposure in pregnant women.
Wu C; Tan Y; Wei X; Li X; Sun S; Lyu B; Shen Z; Wei X; Xiao S; Ruan Y; Yu J; He G; Zheng W; Li J
Toxicol In Vitro; 2024 May; 99():105853. PubMed ID: 38806067
[TBL] [Abstract][Full Text] [Related]
3. Data derived extrapolation factors (DDEFs) for rat to human interspecies extrapolation for the HPPD inhibitor mesotrione.
Pecquet AM; Bridgwood K; Cowie D; Hofstra A; Wu Y; Whalley S; Webb SD
Crit Rev Toxicol; 2024 Jun; ():1-12. PubMed ID: 38869005
[TBL] [Abstract][Full Text] [Related]
4. Physiologically based toxicokinetic modelling as a tool to support risk assessment: three case studies.
Mielke H; Gundert-Remy U
J Toxicol; 2012; 2012():359471. PubMed ID: 22649449
[TBL] [Abstract][Full Text] [Related]
5. PBTK model for assessment of operator exposure to haloxyfop using human biomonitoring and toxicokinetic data.
Cooper AB; Aggarwal M; Bartels MJ; Morriss A; Terry C; Lord GA; Gant TW
Regul Toxicol Pharmacol; 2019 Mar; 102():1-12. PubMed ID: 30543831
[TBL] [Abstract][Full Text] [Related]
6. Development of physiologically-based toxicokinetic-toxicodynamic (PBTK-TD) model for 4-nonylphenol (4-NP) reflecting physiological changes according to age in males: Application as a new risk assessment tool with a focus on toxicodynamics.
Jeong SH; Jang JH; Lee YB
Environ Pollut; 2022 Nov; 312():120041. PubMed ID: 36030954
[TBL] [Abstract][Full Text] [Related]
7. A generic PBTK model implemented in the MCRA platform: Predictive performance and uses in risk assessment of chemicals.
Tebby C; van der Voet H; de Sousa G; Rorije E; Kumar V; de Boer W; Kruisselbrink JW; Bois FY; Faniband M; Moretto A; Brochot C
Food Chem Toxicol; 2020 Aug; 142():111440. PubMed ID: 32473292
[TBL] [Abstract][Full Text] [Related]
8. Development and intercomparison of single and multicompartment physiologically-based toxicokinetic models: Implications for model selection and tiered modeling frameworks.
Armitage JM; Hughes L; Sangion A; Arnot JA
Environ Int; 2021 Sep; 154():106557. PubMed ID: 33892222
[TBL] [Abstract][Full Text] [Related]
9. Development and application of the physiologically-based toxicokinetic (PBTK) model for ochratoxin A (OTA) in rats and humans.
Su BD; Li XM; Huang ZW; Wang Y; Shao J; Xu YY; Shu LX; Li YB
Ecotoxicol Environ Saf; 2024 May; 276():116277. PubMed ID: 38604061
[TBL] [Abstract][Full Text] [Related]
10. Toxicokinetics and toxicodynamics of ochratoxin A, an update.
Ringot D; Chango A; Schneider YJ; Larondelle Y
Chem Biol Interact; 2006 Jan; 159(1):18-46. PubMed ID: 16293235
[TBL] [Abstract][Full Text] [Related]
11. Ochratoxin A kinetics: a review of analytical methods and studies in rat model.
Vettorazzi A; González-Peñas E; de Cerain AL
Food Chem Toxicol; 2014 Oct; 72():273-88. PubMed ID: 25057808
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
